Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial

od Quillien, Véronique, Lavenu, Audrey, Ducray, François, Joly, Marie-Odile, Chinot, Olivier, Fina, Frédéric, Sanson, Marc, Carpentier, Catherine, Karayan-Tapon, Lucie, Rivet, Pierre, Entz-Werle, Natacha, Legrain, Michèle, Zalcman, Emmanuèle Lechapt, Levallet, Guenaelle, Escande, Fabienne, Ramirez, Carole, Chiforeanu, Dan, Vauleon, Elodie, Figarella-Branger, Dominique
izdano v Oncotarget (2016)